The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis

References

• Buchanan W. W., Rooney P. J., Rennie J. A. N. Aspirin and the salicylates. Clin. Rheum. Dis 1982; 5: 499–5391. Buchanan W. W., Rooney P. J., Rennie J. A. N. Aspirin and the salicylates. Clin. Rheum. Dis 1982; 5: 499–539
   Google Scholar
• Champion C. D., Day R. O., Graham G. G., Paull P. D. Salicylates in rheumatoid arthritis. Clin. Rheum. Dis 1975; 1: 245–2652. Champion C. D., Day R. O., Graham G. G., Paull P. D. Salicylates in rheumatoid arthritis. Clin. Rheum. Dis 1975; 1: 245–265
   Google Scholar
• Dipasquale G., Rassaert C., Richter R. The anti-inflammatory properties of isoxicam. Agents Action 1975; 5: 256–2633. Dipasquale G., Rassaert C., Richter R. The anti-inflammatory properties of isoxicam. Agents Action 1975; 5: 256–263
   PubMedGoogle Scholar
• Downie W. W. Comparative studies of isoxicam in rheumatoid arthritis. Semin. Arthritis Rheum 1982; 12(Suppl. 2)170–1784. Downie W. W. Comparative studies of isoxicam in rheumatoid arthritis. Semin. Arthritis Rheum 1982; 12(Suppl. 2)170–178
   Web of Science ®Google Scholar
• Downie W. W., Leatham P. A., Rhind V. M., Wright V., Branco J. A., Anderson J. A. Studies with pain rating scales. Ann. Rheum. Dis 1978; 37: 378–3815. Downie W. W., Leatham P. A., Rhind V. M., Wright V., Branco J. A., Anderson J. A. Studies with pain rating scales. Ann. Rheum. Dis 1978; 37: 378–381
   PubMed Web of Science ®Google Scholar
• Fogari R., Bonebrake R. A. Aspirin and placebo controlled study of isoxicam in the treatment of rheumatoid arthritis. Semin. Arthritis Rheum 1982; 12(Suppl. 2)165–1696. Fogari R., Bonebrake R. A. Aspirin and placebo controlled study of isoxicam in the treatment of rheumatoid arthritis. Semin. Arthritis Rheum 1982; 12(Suppl. 2)165–169
   Web of Science ®Google Scholar
• Gowans J. D. C. Placebo-controlled multicenter studies in the treatment of rheumatoid arthritis and degenerative joint disease. Semin. Arthritis Rheum 1982; 12(Suppl. 2)160–1647. Gowans J. D. C. Placebo-controlled multicenter studies in the treatment of rheumatoid arthritis and degenerative joint disease. Semin. Arthritis Rheum 1982; 12(Suppl. 2)160–164
   Web of Science ®Google Scholar
• Helewa A., Goldsmith C. H., Smythe H. A. The modified sphygmomano-meter. An instrument to measure muscle strength: a validation study. J. Chron. Dis 1981; 34: 353–3618. Helewa A., Goldsmith C. H., Smythe H. A. The modified sphygmomano-meter. An instrument to measure muscle strength: a validation study. J. Chron. Dis 1981; 34: 353–361
   PubMedGoogle Scholar
• Mills J. A., Pinals R. S., Ropes M. W., Short C. L., Sutcliffe J. Value of bed rest in patients with rheumatoid arthritis. N. Engl. J. Med 1971; 284: 453–4589. Mills J. A., Pinals R. S., Ropes M. W., Short C. L., Sutcliffe J. Value of bed rest in patients with rheumatoid arthritis. N. Engl. J. Med 1971; 284: 453–458
   PubMed Web of Science ®Google Scholar
• Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q. J. Med 1968; 37: 393–40610. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q. J. Med 1968; 37: 393–406
   PubMedGoogle Scholar
• Ropes M. W., Bennett G. A., Cobb S., Jacox R., Jessar R. A. Diagnostic criteria for rheumatoid arthritis: 1958 revision. Ann. Rheum. Dis 1959; 18: 49–5111. Ropes M. W., Bennett G. A., Cobb S., Jacox R., Jessar R. A. Diagnostic criteria for rheumatoid arthritis: 1958 revision. Ann. Rheum. Dis 1959; 18: 49–51
   PubMed Web of Science ®Google Scholar
• Sheiner L. B., Beal S. L. Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data. J. Pharm. Biopharm 1980; 8: 553–57112. Sheiner L. B., Beal S. L. Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data. J. Pharm. Biopharm 1980; 8: 553–571
   PubMedGoogle Scholar
• Yakatan G. Pharmacology and pharmacokinetics of isoxicam. Semin. Arthritis Rheum 1982; 12(Suppl. 2)154–15913. Yakatan G. Pharmacology and pharmacokinetics of isoxicam. Semin. Arthritis Rheum 1982; 12(Suppl. 2)154–159
   Web of Science ®Google Scholar